Circulatory c-type natriuretic peptide reduces mucopolysaccharidosis-associated craniofacial hypoplasia in vivo

HIGHLIGHTS

  • who: Marina Kashiwagi et al. from the Department of Oral and Maxillofacial Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan, Department of Medical Secretarial Arts, Kansai Women`s College, Japan have published the paper: Circulatory C-type natriuretic peptide reduces mucopolysaccharidosis-associated craniofacial hypoplasia in vivo, in the Journal: PLOS ONE of October/20,/2022
  • what: The authors analysed the craniofacial morphology of mice with MPS VII and investigated the underlying mechanisms promoting jaw deformities in these animals.
  • how: The authors analysed the head and neck morphology of MPS type VII model . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?